发明名称 |
USE OF SOLUBLE CD160 TO SUPPRESS IMMUNITY |
摘要 |
Pharmaceutical composition comprising a soluble form of CD160 for treating an inflammatory condition involving an undesired immune response, such as tissue graft or organ rejection, and autoimmune diseases; in vitro method for screening an individual for the presence of an inflammatory condition such as infectious and autoimmune diseases, tissue graft and organ rejection, or the presence of a tumor or activated endothelial cells, or for monitoring therapy of an inflammatory condition such as an autoimmune disorder or a tissue or organ rejection, or a tumor during chemotherapy including treatment with an anti- angiogenic substance or antibody. |
申请公布号 |
WO2008009711(A3) |
申请公布日期 |
2008.04.24 |
申请号 |
WO2007EP57447 |
申请日期 |
2007.07.18 |
申请人 |
INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE);BENSUSSAN, ARMAND;BOUMSELL, LAURENCE;ORTONNE, NICOLAS |
发明人 |
BENSUSSAN, ARMAND;BOUMSELL, LAURENCE;ORTONNE, NICOLAS |
分类号 |
A61K38/17;A61P37/06 |
主分类号 |
A61K38/17 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|